Fmr LLC Fulcrum Therapeutics, Inc. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 5,329,946 shares of FULC stock, worth $18.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,329,946

Previous 5,364,665 0.65%

Holding current value

$18.6 Million

Previous $50.6 Million 34.75%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$5.98 - $9.31 $207,619 - $323,233	-34,719 Reduced 0.65%	5,329,946 $33 Million
Q1 2024 May 13, 2024	SELL	$6.7 - $12.0 $2.14 Million - $3.84 Million	-319,950 Reduced 5.63%	5,364,665 $50.6 Million
Q4 2023 Feb 13, 2024	SELL	$3.18 - $6.86 $924,747 - $1.99 Million	-290,801 Reduced 4.87%	5,684,615 $38.4 Million
Q3 2023 Nov 13, 2023	BUY	$3.25 - $6.08 $1.37 Million - $2.56 Million	421,676 Added 7.59%	5,975,416 $26.5 Million
Q2 2023 Aug 11, 2023	SELL	$2.26 - $3.8 $1.36 Million - $2.29 Million	-602,588 Reduced 9.79%	5,553,740 $18.3 Million
Q1 2023 May 11, 2023	BUY	$2.83 - $13.99 $2.61 Million - $12.9 Million	922,603 Added 17.63%	6,156,328 $17.5 Million
Q4 2022 Feb 13, 2023	SELL	$5.01 - $8.35 $12.9 Million - $21.5 Million	-2,571,917 Reduced 32.95%	5,233,725 $38.1 Million
Q3 2022 Nov 10, 2022	BUY	$4.92 - $9.1 $8.26 Million - $15.3 Million	1,678,411 Added 27.39%	7,805,642 $63.1 Million
Q2 2022 Aug 12, 2022	BUY	$4.2 - $24.0 $129,162 - $738,072	30,753 Added 0.5%	6,127,231 $30 Million
Q1 2022 May 13, 2022	BUY	$9.96 - $23.65 $141,043 - $334,907	14,161 Added 0.23%	6,096,478 $144 Million
Q4 2021 Feb 14, 2022	BUY	$14.0 - $28.44 $525,756 - $1.07 Million	37,554 Added 0.62%	6,082,317 $108 Million
Q3 2021 Nov 15, 2021	BUY	$7.28 - $30.97 $26.7 Million - $114 Million	3,665,282 Added 154.04%	6,044,763 $171 Million
Q2 2021 Aug 13, 2021	BUY	$8.09 - $12.0 $19.3 Million - $28.6 Million	2,379,481 New	2,379,481 $24.9 Million

Others Institutions Holding FULC

# of Institutions

137

Shares Held

59M

Call Options Held

4.33M

Put Options Held

351K

View Full List

About Fulcrum Therapeutics, Inc.

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $182M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

More about FULC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account